IMPULSE DYNAMICS ANNOUNCES PUBLICATION OF DATA FROM FIX-HF-5C2 STUDY EVALUATING THE TWO-LEAD OPTIMIZER SYSTEM [Link: https://impulse-dynamics.com/blog/2020/04/14/impulse-dynamics-announces-publication-of-data-from-fix-hf-5c2-study-evaluating-the-two-lead-optimizer-system/]
IMPULSE DYNAMICS ANNOUNCES FIRST ENROLLMENT IN POST-APPROVAL STUDY OF CCM THERAPY DELIVERED BY THE OPTIMIZER SYSTEM [Link: https://impulse-dynamics.com/blog/2020/03/17/impulse-dynamics-announces-first-enrollment-in-post-approval-study-of-ccm-therapy-delivered-by-the-optimizer-system/]
2020 Payment Rules from the Centers for Medicare and Medicaid Services Bring CCM Therapy to Heart Failure Patients in the Outpatient Setting [Link: https://impulse-dynamics.com/blog/2019/11/05/impulse-dynamics-secures-transitional-pass-through-tpt-incremental-payment-for-the-optimizer-smart-system/]
IMPULSE DYNAMICS ANNOUNCES U.S. FDA SUPPLEMENTAL-PMA APPROVAL OF ITS NEXT GENERATION OPTIMIZER® SMART SYSTEM [Link: https://impulse-dynamics.com/blog/2019/10/30/impulse-dynamics-announces-u-s-fda-supplemental-pma-approval-of-its-next-generation-optimizer-smart-system/]
IMPULSE DYNAMICS RECEIVES FDA APPROVAL FOR BREAKTHROUGH OPTIMIZER® SMART SYSTEM DELIVERING CCM™ THERAPY FOR TREATMENT OF HEART FAILURE [Link: https://impulse-dynamics.com/blog/2019/03/21/impulse-dynamics-receives-fda-approval-for-breakthrough-optimizer-smart-system-delivering-ccm-therapy-for-treatment-of-heart-failure/]
CLINICAL REGISTRY DATA AND RECENTLY PUBLISHED FIX-HF-5C WERE PRESENTED AT THE LATE-BREAKING CLINICAL TRIAL SESSION AT EHF 2018 [Link: https://impulse-dynamics.com/blog/2018/05/28/clinical-registry-data-and-recently-published-fix-hf-5c-were-presented-at-the-late-breaking-clinical-trial-session-at-ehf-2018/]
